Skip to main content
editorial
. 2025 Nov 5;13(11):2714. doi: 10.3390/biomedicines13112714
DIF Direct Skin Immunofluorescence
BPAG1 Bullous Pemphigoid Antigen 1
BPAG2 Bullous Pemphigoid Antigen 2
IHC Immunohistochemistry
PUVA Psoralen Ultraviolet A
CD Cluster of Differentiating Antigens
Ig Immunoglobulin
HLA-C*06:02 Human Leukocyte Antigen *06:02
HLA-Cw6 Human Leukocyte Antigen Cw6
TNF-α, IL cytokines
Th T helper cell
T reg Regulatory T cell
scRNA-seq Single-Cell RNA Sequencing
BRAF B-Raf proto-oncogene, serine/threonine kinase
NRAS Neuroblastoma RAS viral oncogene homolog
c-Kit CD117
ctDNA NF1 circulating tumour DNA
CTDCs circulating tumour cells.
MEK Mitogen-Activated Protein Kinase
MELTUMP MELanocytic Tumour of Uncertain Malignant Potential.
PRAME PReferentially expresses Antigen in MElanoma
SOX10 SRY-related HMG-box protein 10
Ki-67 protein involved in cell division and proliferation
HMB45 Human Melanoma Black 45
PD-1 Programmed death-1 protein
CTLA-4 Cytotoxic T-lymphocyte antigen 4
VIP Vasoactive intestinal peptide
UVR Ultraviolet ray
DAMPS Damage/Danger-Associated Molecular Patterns
TLRs Toll-like Receptors
STD Sexually transmitted diseases
TROMPs Treponema Outer Membrane Proteins
LOSs Gonococcal lipo-oligosaccharide
IFN-γ Interferon γ
PMNs Neutrophils
NAAT Nucleic acid amplification test
BCC Basal cell carcinoma
CTC Circulating tumour cell
LDH Lactate dehydrogenase
BIOMAP consortium Biopharmaceutical Manufacturing Preparedness Consortium
LCE3D Late Cornified Envelope Family in Differentiating Epithelia
NFKBIL1 NF-kappa-B inhibitor-like protein 1
HDL High-Density-Lipoprotein
GlycA Glycosylated Acute-Phase Proteins
I-FABP Intestinal Fatty Acid-Binding Protein
CXCL10 C-X-C motif chemokine 10
SALT Skin-associated lymphoid tissue
DCs Dendritic cells
LoS Localised scleroderma
SS Systemic scleroderma
(CAR) T cells Chimeric Antigen Receptor for T cells